Avac (Aids Vaccine and Advocacy Coalition)
AVAC works to ensure ethical development of and access to effective HIV prevention options
Based in NY
🤖
AI Overview
With $260K in lobbying spend across 12 quarterly filings, Avac (Aids Vaccine and Advocacy Coalition) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2025.
$260K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $80K |
| 2024 | $80K |
| 2025 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
- •Advocate for inclusion of funding and report language to resource and direct CDC to develop and launch a national PrEP program to provide PrEP (HIV prevention medication) to people in need nationwide
- •Advocated for inclusion in the FY24 Labor, Health and Human Services, Education and Related Agencies (LHHS) appropriations bill funding and report language to resource and direct CDC to further develo
- •Advocate for inclusion of funding and report language to resource and direct CDC to develop and support a national PrEP program to provide PrEP (HIV prevention medication) to people in need nationwide
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.